$350 | Single User
$700 | Site License
$1050 | Enterprise License

Pharmaceuticals in Asia-Pacific [Report Updated: 06-06-2018]

Published by Marketline: 06 Jun 2018 | 218199 | In Stock

Introduction

Pharmaceuticals in Asia-Pacific

Summary

Pharmaceuticals in Asia-Pacific industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2013-17, and forecast to 2022). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Synopsis

Essential resource for top-line data and analysis covering the Asia-Pacific pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Key highlights

- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.

- The Asia-Pacific pharmaceuticals market had total revenues of 1.0bn in 2017, representing a compound annual growth rate (CAGR) of 6.4% between 2013 and 2017.

- Countries such as China, India and Indonesia are experiencing strong growth due to a bourgeoning middle class which spend more on health and greater awareness of chronic diseases.

- South Korea and Japan contrast the performance of the region as a whole. Low rates of growth show those markets are mature and pressure is exerted on leading pharmaceutical companies to keep costs down amid greater demands being placed upon the healthcare system.

Scope

- Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in Asia-Pacific

- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Asia-Pacific

- Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance

- Add weight to presentations and pitches by understanding the future growth prospects of the Asia-Pacific pharmaceuticals market with five year forecasts

Reasons to buy

- What was the size of the Asia-Pacific pharmaceuticals market by value in 2017?

- What will be the size of the Asia-Pacific pharmaceuticals market in 2022?

- What factors are affecting the strength of competition in the Asia-Pacific pharmaceuticals market?

- How has the market performed over the last five years?

- Who are the top competitiors in Asia-Pacific's pharmaceuticals market?

Table of Contents
for Pharmaceuticals in Asia-Pacific [Report Updated: 06-06-2018]

  • Table of Contents

    Executive Summary 2

    Market value 2

    Market value forecast 2

    Geography segmentation 2

    Market share 2

    Market rivalry 2

    Market Overview 7

    Market definition 7

    Market analysis 7

    Market Data 9

    Market value 9

    Market Segmentation 10

    Geography segmentation 10

    Market share 11

    Market Outlook 12

    Market value forecast 12

    Five Forces Analysis 13

    Summary 13

    Buyer power 15

    Supplier power 17

    New entrants 18

    Threat of substitutes 20

    Degree of rivalry 21

    Leading Companies 23

    Daiichi Sankyo Co Ltd 23

    Shanghai Pharmaceutical Co Ltd 26

    Takeda Pharmaceutical Company Limited 29

    Yangtze River Pharmaceutical Group 32

    Methodology 33

    Industry associations 34

    Related MarketLine research 34

    Appendix 35

    About MarketLine 35

List Of Tables
in Pharmaceuticals in Asia-Pacific [Report Updated: 06-06-2018]

List of Tables

Table 1: Asia-Pacific pharmaceuticals market value: $ billion, 2013-17

Table 2: Asia-Pacific pharmaceuticals market geography segmentation: $ billion, 2017

Table 3: Asia-Pacific pharmaceuticals market share: % share, by value, 2017

Table 4: Asia-Pacific pharmaceuticals market value forecast: $ billion, 2017-22

Table 5: Daiichi Sankyo Co Ltd: key facts

Table 6: Daiichi Sankyo Co Ltd: key financials ($)

Table 7: Daiichi Sankyo Co Ltd: key financials (¥)

Table 8: Daiichi Sankyo Co Ltd: key financial ratios

Table 9: Shanghai Pharmaceutical Co Ltd: key facts

Table 10: Shanghai Pharmaceutical Co Ltd: key financials ($)

Table 11: Shanghai Pharmaceutical Co Ltd: key financials (CNY)

Table 12: Shanghai Pharmaceutical Co Ltd: key financial ratios

Table 13: Takeda Pharmaceutical Company Limited: key facts

Table 14: Takeda Pharmaceutical Company Limited: key financials ($)

Table 15: Takeda Pharmaceutical Company Limited: key financials (¥)

Table 16: Takeda Pharmaceutical Company Limited: key financial ratios

Table 17: Yangtze River Pharmaceutical Group: key facts

List Of Figures, Charts and Diagrams
in Pharmaceuticals in Asia-Pacific [Report Updated: 06-06-2018]

List of Figures

Figure 1: Asia-Pacific pharmaceuticals market value: $ billion, 2013-17

Figure 2: Asia-Pacific pharmaceuticals market geography segmentation: % share, by value, 2017

Figure 3: Asia-Pacific pharmaceuticals market share: % share, by value, 2017

Figure 4: Asia-Pacific pharmaceuticals market value forecast: $ billion, 2017-22

Figure 5: Forces driving competition in the pharmaceuticals market in Asia-Pacific, 2017

Figure 6: Drivers of buyer power in the pharmaceuticals market in Asia-Pacific, 2017

Figure 7: Drivers of supplier power in the pharmaceuticals market in Asia-Pacific, 2017

Figure 8: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Asia-Pacific, 2017

Figure 9: Factors influencing the threat of substitutes in the pharmaceuticals market in Asia-Pacific, 2017

Figure 10: Drivers of degree of rivalry in the pharmaceuticals market in Asia-Pacific, 2017

Figure 11: Daiichi Sankyo Co Ltd: revenues & profitability

Figure 12: Daiichi Sankyo Co Ltd: assets & liabilities

Figure 13: Shanghai Pharmaceutical Co Ltd: revenues & profitability

Figure 14: Shanghai Pharmaceutical Co Ltd: assets & liabilities

Figure 15: Takeda Pharmaceutical Company Limited: revenues & profitability

Figure 16: Takeda Pharmaceutical Company Limited: assets & liabilities

Additional Details

Publisher

Marketline

Publisher Information

Reference

218199 |

Number of Pages

36

Report Format

PDF

Marketline Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Alexion Pharmaceuticals Partnering Deals and Alliances 2010 to 2016
The Partnering Deals and Alliance since 2010 report provides an in-depth insight into the partnering...
01 Oct 2016 by Current Partnering USD $1,495 More Info
Alnylam Pharmaceuticals Partnering Deals and Alliances 2010 to 2016
The Partnering Deals and Alliance since 2010 report provides an in-depth insight into the partnering...
01 Oct 2016 by Current Partnering USD $1,495 More Info
AMAG Pharmaceuticals Partnering Deals and Alliances 2010 to 2016
The Partnering Deals and Alliance since 2010 report provides an in-depth insight into the partnering...
01 Oct 2016 by Current Partnering USD $1,495 More Info
Amylin Pharmaceuticals Partnering Deals and Alliances 2010 to 2016
The Partnering Deals and Alliance since 2010 report provides an in-depth insight into the partnering...
01 Oct 2016 by Current Partnering USD $1,495 More Info
BioCryst Pharmaceuticals Partnering Deals and Alliances 2010 to 2016
The Partnering Deals and Alliance since 2010 report provides an in-depth insight into the partnering...
01 Oct 2016 by Current Partnering USD $1,495 More Info
Biomarin Pharmaceuticals Partnering Deals and Alliances 2010 to 2016
The Partnering Deals and Alliance since 2010 report provides an in-depth insight into the partnering...
01 Oct 2016 by Current Partnering USD $1,495 More Info
Enzon Pharmaceuticals Partnering Deals and Alliances 2010 to 2016
The Partnering Deals and Alliance since 2010 report provides an in-depth insight into the partnering...
01 Oct 2016 by Current Partnering USD $1,495 More Info
Essilor Pharmaceuticals Partnering Deals and Alliances 2010 to 2016
The Partnering Deals and Alliance since 2010 report provides an in-depth insight into the partnering...
01 Oct 2016 by Current Partnering USD $1,495 More Info
Isis Pharmaceuticals Partnering Deals and Alliances 2010 to 2016
The Partnering Deals and Alliance since 2010 report provides an in-depth insight into the partnering...
01 Oct 2016 by Current Partnering USD $1,495 More Info
NPS Pharmaceuticals Partnering Deals and Alliances 2010 to 2016
The Partnering Deals and Alliance since 2010 report provides an in-depth insight into the partnering...
01 Oct 2016 by Current Partnering USD $1,495 More Info

This report is published by Marketline

Download Free Report Summary PDF

Pharmaceuticals in Asia-Pacific [Report Updated: 06-06-2018] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...

  • Allied Market Research
  • CBR Pharma
  • Current Partnering
  • Firstword
  • Global Data
  • Global Markets Direct
  • ICD Research
  • Infinti Research Technavio
  • Marketline
  • Markets and Markets
  • Micro Markets Monitor
  • MP Advisors
  • Venture Planning Group
  • GMR Data